Atlas Trials

Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix

Clinical trial NCT03644342 · TERMINATED

Trial details

NCT number
NCT03644342
Sponsor
Michelle S Ludwig
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Carcinoma of the Cervix
Start date
2019-07-15
Primary completion
2022-04-18
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.